Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Wang

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Nanoscale|July 17, 2018
T-Nb<sub>2</sub>O<sub>5</sub> nanoparticle enabled pseudocapacitance with fast Li-ion intercalationLingping Kong, Xiaoteng Liu, Jinjia Wei, et al.
Pain|June 11, 2013
Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis painPanna Sanga, Nathaniel Katz, Elena Polverejan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 18, 2016
Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of PhotoagingManpreet Randhawa, Steven Wang, James J Leyden, et al.
Neurobiology of Disease|November 7, 2012
Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpressionRenatta Knox, Chong Zhao, Dario Miguel-Perez, et al.
The Journal of Pain|October 28, 2018
Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyNeal Slatkin, Naim Zaki, Steven Wang, et al.
Current Medical Research and Opinion|August 8, 2019
Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studiesKathleen M Kelly, Panna Sanga, Naim Zaki, et al.
The Biochemical Journal|October 24, 2012
Role of the repressor Oaf3p in the recruitment of transcription factors and chromatin dynamics during the oleate responseYakun Wan, Christina E Arens, Steven Wang, et al.
Expert Opinion on Drug Safety|February 20, 2025
Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping reviewRashudy Fatiha Mahomedradja, Steven Wang, Kim Catherina Eve Sigaloff, et al.
Headache|November 23, 2006
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safetyPaul Winner, Astrid Gendolla, Catherine Stayer, et al.
Journal of Child Neurology|July 21, 2007
Topiramate monotherapy in newly diagnosed epilepsy in children and adolescentsTracy A Glauser, Dennis J Dlugos, W Edwin Dodson, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Nanoscale|July 17, 2018
T-Nb<sub>2</sub>O<sub>5</sub> nanoparticle enabled pseudocapacitance with fast Li-ion intercalationLingping Kong, Xiaoteng Liu, Jinjia Wei, et al.
Pain|June 11, 2013
Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis painPanna Sanga, Nathaniel Katz, Elena Polverejan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 18, 2016
Daily Use of a Facial Broad Spectrum Sunscreen Over One-Year Significantly Improves Clinical Evaluation of PhotoagingManpreet Randhawa, Steven Wang, James J Leyden, et al.
Neurobiology of Disease|November 7, 2012
Enhanced NMDA receptor tyrosine phosphorylation and increased brain injury following neonatal hypoxia-ischemia in mice with neuronal Fyn overexpressionRenatta Knox, Chong Zhao, Dario Miguel-Perez, et al.
The Journal of Pain|October 28, 2018
Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyNeal Slatkin, Naim Zaki, Steven Wang, et al.
Current Medical Research and Opinion|August 8, 2019
Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studiesKathleen M Kelly, Panna Sanga, Naim Zaki, et al.
The Biochemical Journal|October 24, 2012
Role of the repressor Oaf3p in the recruitment of transcription factors and chromatin dynamics during the oleate responseYakun Wan, Christina E Arens, Steven Wang, et al.
Expert Opinion on Drug Safety|February 20, 2025
Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping reviewRashudy Fatiha Mahomedradja, Steven Wang, Kim Catherina Eve Sigaloff, et al.
Headache|November 23, 2006
Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safetyPaul Winner, Astrid Gendolla, Catherine Stayer, et al.
Journal of Child Neurology|July 21, 2007
Topiramate monotherapy in newly diagnosed epilepsy in children and adolescentsTracy A Glauser, Dennis J Dlugos, W Edwin Dodson, et al.
Pageof 16